Greenwich LifeSciences, Inc.: Greenwich LifeSciences Provides Additional Updates on FLAMINGO-01 and Corporate Strategy

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01 ...
Dentistry

The role of mouthwash in periodontal care

Professor Iain Chapple explains how updated clinical guidance clarifies when and how mouthwash can enhance periodontal care.

Health Canada authorizes TNKase® (tenecteplase) for the treatment of Acute Ischemic Stroke (AIS)

Hoffmann-La Roche Limited (Roche Canada) is proud to announce that Health Canada has granted market authorization for TNKase® ...

Arch Biopartners Announces Ethics Approval for St. Michael’s Hospital to Participate in the Phase II Cardiac Surgery-Associated AKI Trial for LSALT Peptide

Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced today that the University ...

New technique lights up where drugs go in the body, cell by cell

When you take a drug, where in your body does it actually go? For most medications, scientists can make only educated guesses ...
The Cardiology Advisor

LDL-C-Lowering Therapy Lerochol Gains FDA Approval

The FDA approved Lerochol, a monthly PCSK9 inhibitor, for adults with hypercholesterolemia to reduce LDL-C levels alongside diet and exercise.